3-(Butylaminomethyl)-6-methoxy-2,3-dihydrochromen-4-one

ID: ALA3637805

Chembl Id: CHEMBL3637805

PubChem CID: 4431837

Max Phase: Preclinical

Molecular Formula: C15H21NO3

Molecular Weight: 263.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCNCC1COc2ccc(OC)cc2C1=O

Standard InChI:  InChI=1S/C15H21NO3/c1-3-4-7-16-9-11-10-19-14-6-5-12(18-2)8-13(14)15(11)17/h5-6,8,11,16H,3-4,7,9-10H2,1-2H3

Standard InChI Key:  GTHFECLUXGSWER-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis H37Rv (422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis variant bovis (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 263.34Molecular Weight (Monoisotopic): 263.1521AlogP: 2.28#Rotatable Bonds: 6
Polar Surface Area: 47.56Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 2.07CX LogD: 0.02
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.80Np Likeness Score: 0.50

References

1. Rebollo-Lopez, M. J.; Lelièvre, J.; Alvarez-Gomez, D.; Castro-Pichel, J.; Martínez-Jiménez, F.; Papadatos, G.; Kumar, V.; Colmenarejo, G.; Mugumbate, G.; Hurle, M.; Barroso, V.; Young, R. J.; Martinez-Hoyos, M.; González del Río, R.; Bates, R. H.; Lopez-Roman, E. M.; Mendoza-Losana, A.; Brown, J. R.; Alvarez-Ruiz, E.; Marti-Renom, M. A.; Overington, J. P.; Cammack, N.; Ballell, L.; Barros-Aguire, D., . GSK Tres Cantos Follow-up TB Screening Data.,  [10.6019/CHEMBL3637782]

Source